Amundi’s Nuvalent NUVL Stock Holding History

Amundi’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$454K	Buy	+3,679	New	+$396K	﹤0.01%	1682
2023 Q1	–	Sell	-1,158	Closed	-$34.2K	–	2103
2022 Q4	$34.2K	Buy	+1,158	New	+$32.3K	﹤0.01%	1745

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Amundi's NUVL Position: Q2 2026 in Review

Amundi opened a new position in Nuvalent (NUVL) in Q2 2026: 3,679 shares worth $454K. The stake represents ﹤0.01% of the portfolio and ranks #1682 among its holdings. This is a return to the name: Amundi previously reported a position in NUVL as recently as Q4 2022.

Amundi first reported a position in NUVL in Q4 2022 and has held it in 2 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Amundi held 3,679 shares of Nuvalent worth $454K as of Q2 2026.
Nuvalent was a new Amundi position in Q2 2026.
Nuvalent made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1682 holding.
Amundi first reported a position in Nuvalent in Q4 2022 and has held it in 2 quarters since.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.